(Q73234065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

8

Graham DY

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Lanza F

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Schwartz H

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sahba B

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Malaty HM

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Musliner T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Reyes R

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Quan H

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

3112-3117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Comparative study of potential for bisphosphonates to damage gastric mucosa of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Alendronate gastric ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Upper gastrointestinal toxicity of alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Role of endoscopy in nonsteroidal anti-inflammatory drug clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Esophagitis associated with the use of alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

Esophageal irritation due to alendronate sodium tablets: possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2000.03258.X

10.1111/J.1572-0241.2000.03258.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11095326%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference